Loading insider details...
Latest Form 4 (Nov 4, 2026): Purchase of 8,305 LYCA shares, $223.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Lycia Therapeutics, Inc. (LYCA) | Purchase | 8,305 | $223.8K |
| Oct 30, 2026 | Lycia Therapeutics, Inc. (LYCA) | Purchase | 10,570 | $266.7K |
| Oct 27, 2026 | Lycia Therapeutics, Inc. (LYCA) | Purchase | 24,560 | $630.7K |
| Mar 27, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Sale | 174,485 | $2.96M |
| Apr 11, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 25,000 | $235.5K |
| Feb 27, 2025 | Oruka Therapeutics, Inc. (ORKA) | Purchase | 574 | $6.3K |
| Feb 15, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 100,000 | $923.0K |
| Feb 12, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 73,649 | $684.2K |
| Feb 4, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 43,707 | $382.9K |
| Feb 22, 2024 | KalVista Pharmaceuticals, Inc. (KALV) | Purchase | 655,738 | $10.00M |